EichorEICHOR
Location: Troy Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Troy

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Michigan Institute of Urology, PC · Pfizer · NCT07028853A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · Harmony Biosciences Management, Inc. · NCT07500090Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 7072 · Galderma R&D · NCT06988605A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Merck Sharp & Dohme LLC · NCT07266831This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Corewell Health Beaumont Troy Hospital · NRG Oncology · NCT05624996A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · Michigan Institute of Urology · SURGE Therapeutics · NCT05710848Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Janssen Research & Development, LLC · NCT07499232Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Upper Valley Medical Center · PrECOG, LLC. · NCT06538038A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Gilead Sciences · NCT07645287MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Comprehensive Breast Care · Agendia · NCT03053193Visugromab in Cachexia International Trial
Phase 2/Phase 3 · CatalYm GmbH · NCT07112196A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Pfizer · NCT07144280Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Upper Valley Medical Center · SWOG Cancer Research Network · NCT06769126Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Corewell Health Beaumont Troy Hospital · NRG Oncology · NCT05946213A Study of IBI363 in Subjects with Advanced Solid Malignancies
Phase 2 · Michigan Hematology & Oncology Consultants - MedOnc Troy · Innovent Biologics (Suzhou) Co. Ltd. · NCT06281678Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Michigan Institute of Urology (Solaris) · CG Oncology, Inc. · NCT06567743EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Amgen · NCT07005128Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Phase 4 · Wake Forest University Health Sciences · NCT05421741Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Corewell Health Beaumont Troy Hospital · NRG Oncology · NCT05174169Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Dayton Physicians LLC - Troy · Alliance for Clinical Trials in Oncology · NCT06632327Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · Arcturus Healthcare, Public Limited Company, Troy Internal M · Amgen · NCT07575399Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Phase 2 · Yarrow Bioscience, Inc. · NCT07682896ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Upper Valley Medical Center · Alliance for Clinical Trials in Oncology · NCT06876714This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Sanofi · NCT07290803A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Phase 2 · Arcturus Healthcare - Troy Internal Medicine Research Divisi · Boehringer Ingelheim · NCT07662122Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Dayton Physicians LLC - Troy · National Cancer Institute (NCI) · NCT04269902
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.